Every year, an estimated 150,000 to 200,000 babies worldwide are born with clubfoot, and the vast majority — roughly 80% — are born in low- and middle-income countries. Access to clubfoot developing countries treatment has historically been limited, leaving millions of people with untreated deformity, disability, and social exclusion. But that picture is changing. Over the past two decades, a global movement to bring the Ponseti method to underserved regions has transformed outcomes for children who would previously have faced a lifetime of walking on the sides or tops of their feet.
This article examines the scale of the challenge, the organisations driving progress, the barriers that remain, and the remarkable success stories emerging from programmes across Africa, Asia, and South America.
The Scale of the Problem
Clubfoot affects approximately 1 in 800 live births globally, with significant variation between populations. Rates are highest in certain Pacific Island nations (up to 7 per 1,000) and parts of Sub-Saharan Africa, and lowest in East Asian populations (approximately 0.5 per 1,000).
The Treatment Gap
In the UK, virtually every baby born with clubfoot receives treatment — typically the Ponseti method — within weeks of birth. The NHS provides casting, bracing, and follow-up at no cost to the family. This is not the reality for most of the world.
In many low-income countries, particularly in rural areas:
- There are fewer than one orthopaedic surgeon per million people (compared with approximately 60 per million in the UK)
- Specialist paediatric orthopaedic care may only be available in capital cities, hundreds of kilometres from rural families
- Families cannot afford transport costs, time off work, or the multiple hospital visits that serial casting requires
- Cultural beliefs about disability may lead to children being hidden from health services rather than brought for treatment
- Lack of awareness among primary healthcare workers means cases are not identified or referred
The result is that millions of children and adults in developing countries live with untreated clubfoot. Without treatment, the affected foot becomes progressively more rigid and deformed. People walk on the dorsum (top) or lateral border of their foot, developing painful calluses, infections, and severe difficulty with mobility. The disability affects education (children cannot walk to school), employment (adults cannot work productively), and social participation (stigma and exclusion are common).
Why the Ponseti Method Changed Everything
Before the widespread adoption of the Ponseti method, clubfoot treatment in developing countries typically meant extensive surgery — posterior medial release, soft tissue reconstruction, or even amputation in extreme cases. Surgery requires operating theatres, trained surgeons, anaesthesia, and post-operative care that most resource-limited settings simply cannot provide.
The Ponseti method transformed this equation for several critical reasons:
Low Cost
A full course of Ponseti treatment — including plaster of Paris for casting, a simple percutaneous Achilles tenotomy, and locally manufactured braces — costs approximately £150-300 per child. Compare this with surgical correction, which can cost thousands of pounds and requires infrastructure that does not exist in many settings.
Task-Shifting Potential
While the Ponseti method was originally described and performed by an orthopaedic surgeon (Dr. Ignacio Ponseti at the University of Iowa), the technique can be taught to non-specialist practitioners. Physiotherapists, clinical officers, orthopaedic technicians, and even specially trained nurses have successfully delivered Ponseti casting in developing country programmes. This "task-shifting" approach dramatically increases the number of healthcare workers who can treat clubfoot.
High Success Rate
Even in resource-limited settings, Ponseti treatment achieves initial correction rates of 90-98% — comparable to results in high-income countries. The method works regardless of the practitioner's background, provided they are properly trained and supervised.
Bracing Can Be Manufactured Locally
The boots and bar (foot abduction brace) used during the maintenance phase can be manufactured in-country using local materials. Several designs have been developed specifically for low-resource settings, including the MiracleFeet brace and the Steenbeek foot abduction brace (an open-source design that can be made from locally available materials for under $10).
Major Global Programmes
Several organisations have been instrumental in scaling Ponseti treatment across the developing world.
MiracleFeet
MiracleFeet (formerly known as the Global Clubfoot Initiative's operational arm) operates in over 30 countries across Africa, Asia, and Latin America. Their model involves:
- Training local healthcare workers in the Ponseti method
- Establishing treatment clinics within existing health facilities
- Providing locally manufactured braces at no cost to families
- Implementing community outreach to identify untreated children
- Supporting families through the multi-year bracing phase with community health workers
Since its founding, MiracleFeet has supported treatment for over 100,000 children. Their cost per child treated is approximately $500 (£400) for the complete treatment cycle.
CURE International
CURE operates surgical hospitals in several African countries but has increasingly adopted the Ponseti method as its primary clubfoot treatment. Their clubfoot programme spans multiple countries and focuses on integrating treatment into national health systems rather than creating parallel structures.
CBM (Christian Blind Mission)
CBM, one of the world's largest disability-inclusive development organisations, supports clubfoot treatment programmes in numerous countries. They focus particularly on reaching children in rural and marginalised communities.
National Programmes
Several countries have established their own national clubfoot treatment programmes:
Uganda: The Uganda Sustainable Clubfoot Care Project has integrated Ponseti treatment into the public health system, with trained practitioners at district hospitals across the country. Uganda is considered one of the most successful models of national scale-up.
India: With an estimated 50,000 clubfoot births per year (the highest absolute number of any country), India's CURE Clubfoot programme has established over 600 treatment centres. The programme has treated more than 100,000 children since 2009.
Brazil: Brazil was an early adopter of the Ponseti method in Latin America, with dedicated clubfoot clinics established at public universities and hospitals in multiple states.
Bangladesh: The Walk for Life programme has established clubfoot clinics across Bangladesh, treating thousands of children annually in a country where previously most cases went untreated.
Barriers That Remain
Despite remarkable progress, significant challenges persist.
Late Presentation
In many countries, children present for treatment months or years after birth rather than in the first weeks. Late presentation makes Ponseti treatment more complex — more casts may be needed, the Achilles tenotomy is more likely to require general anaesthesia rather than local, and the relapse rate is higher. Programmes working with the Ponseti method in older children have shown it can still be effective up to age 8-10, but results are better with earlier treatment.
Brace Compliance
The single biggest challenge globally is maintaining brace compliance during the years-long maintenance phase. The boots and bar must be worn for 23 hours per day initially, then at night and during naps for 3-5 years. In settings where families may live in one-room dwellings with limited sleeping arrangements, where children may need to walk long distances to collect water, and where the brace itself may be uncomfortable in tropical heat, compliance rates drop.
Programmes that employ community health workers to visit families regularly, provide brace repairs and replacements, and offer family counselling have significantly better compliance and lower relapse rates.
Relapse Management
When relapse occurs — and rates of 15-40% are reported in developing country programmes, compared with 10-15% in the UK — access to re-treatment is critical. Simple relapses can be managed with additional casting, but more severe relapses may require tibialis anterior transfer surgery, which needs a more skilled surgeon and operating facility.
Cultural and Social Barriers
In some communities, clubfoot is attributed to witchcraft, curses, or maternal wrongdoing. These beliefs can prevent families from seeking medical treatment, delay presentation, or cause families to abandon treatment early. Community education and the involvement of traditional leaders and community health workers are essential for overcoming these barriers.
Conflict and Instability
Countries affected by armed conflict, political instability, or humanitarian crises face particular challenges in maintaining clubfoot treatment programmes. Displacement, destruction of health facilities, loss of trained staff, and disruption of supply chains all interrupt care. Children born into conflict zones are among the least likely in the world to receive clubfoot treatment.
The Human Impact
Behind the statistics are individual lives transformed by treatment — or devastated by its absence.
Untreated Clubfoot: The Reality
Adults with untreated clubfoot face a life of profound disadvantage. Walking is difficult and painful. Many can only manage short distances. Employment options are severely limited. In societies where physical labour is the primary means of earning a living, inability to walk normally means inability to support oneself or one's family. The social stigma compounds the physical disability — in some cultures, individuals with visible deformities face discrimination, reduced marriage prospects, and exclusion from community life.
The Transformation of Treatment
Conversely, children who receive Ponseti treatment — even in the most resource-limited settings — go on to walk, run, attend school, and participate fully in their communities. The treatment does not just correct a foot; it changes a life trajectory. A treated child can attend school (walking the distance required), work in adulthood, and participate as a full member of society.
This is why organisations like MiracleFeet frame clubfoot treatment not as a medical intervention but as an investment in human potential. The cost-effectiveness is extraordinary — a few hundred pounds of treatment in infancy prevents a lifetime of disability.
How the UK Contributes
The UK has played a significant role in global clubfoot treatment through several channels:
- Research: UK universities have contributed to the evidence base for Ponseti treatment in low-resource settings
- Training: British orthopaedic surgeons and physiotherapists volunteer with programmes in developing countries, training local practitioners
- Funding: UK-based charities and the Department for International Development (now FCDO) have supported clubfoot programmes
- STEPS Charity Worldwide: The UK-based clubfoot charity provides support to families globally and advocates for improved treatment access
UK families affected by clubfoot who want to support global efforts can donate to organisations working in developing countries or raise awareness during World Clubfoot Day on June 3rd.
The Road Ahead
The goal of universal clubfoot treatment is ambitious but achievable. Key priorities include:
- Integrating Ponseti treatment into routine neonatal care in every country
- Developing better, cheaper, more comfortable braces for tropical climates
- Establishing sustainable funding models so programmes are not dependent on external donors
- Using mobile technology for case identification, follow-up reminders, and treatment monitoring
- Training sufficient practitioners to meet the need — estimated at 200,000+ new cases per year globally
- Addressing the backlog of older children and adults with untreated clubfoot through adapted Ponseti protocols and surgical services
Frequently Asked Questions
Q: Why is clubfoot more common in developing countries?
A: The birth rate of clubfoot is similar across populations (with some ethnic variation). What differs is the treatment rate. In the UK, essentially all cases are treated. In many developing countries, only a fraction of children born with clubfoot receive treatment. Higher birth rates in developing countries also mean greater absolute numbers. For more on global variation, see our article on why clubfoot is more common in developing countries.
Q: Can the Ponseti method be done without a doctor?
A: Yes, with proper training. The Ponseti method has been successfully delivered by physiotherapists, clinical officers, orthopaedic technicians, and trained nurses in many countries. The key is structured training, ongoing supervision, and access to a surgeon for the Achilles tenotomy component. Task-shifting is one of the reasons the Ponseti method has scaled so successfully in resource-limited settings.
Q: What happens to children in developing countries who do not receive treatment?
A: Without treatment, clubfoot becomes a permanent, progressively worsening disability. The foot becomes increasingly rigid and deformed. Walking is painful and inefficient. Many untreated individuals develop secondary complications including calluses, infections, and joint damage. The disability limits access to education, employment, and social participation.
Q: How can I help as a UK parent of a child with clubfoot?
A: You can support global clubfoot treatment by donating to organisations like MiracleFeet, CURE International, or STEPS Charity Worldwide. Raising awareness during World Clubfoot Day (June 3rd) helps highlight the issue. Some families fundraise specifically for clubfoot treatment programmes — even a small amount goes far, as the cost of treating one child is typically £150-400.
Q: Is surgery still the main treatment in developing countries?
A: Increasingly, no. The shift from surgical to Ponseti-based treatment has been one of the biggest changes in global clubfoot care over the past 20 years. Most major programmes now use the Ponseti method as their primary approach. Surgery is reserved for complex or relapsed cases that do not respond to casting and bracing.
Q: Are locally manufactured braces as effective as the ones used in the UK?
A: Several locally manufactured brace designs have been shown to be effective in clinical studies. The Steenbeek brace, Mitchell brace, and MiracleFeet brace all maintain the foot in the corrected position effectively. The most important factor is not the brand of brace but consistent use — compliance is the key determinant of long-term success regardless of the specific brace used.